Vanguard Group
IMA

Vanguard Group’s ImageneBio Inc IMA Stock Holding History

Vanguard Group’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.64M Buy
238,000
+4,642
+2% +$34.4K ﹤0.01% 3622
2025
Q3 		$1.9M Buy
233,358
+115,554
+98% +$1.53M ﹤0.01% 3597
2025
Q2 		$1.89M Buy
117,804
+2,519
+2% +$37K ﹤0.01% 3551
2025
Q1 		$1.77M Sell
115,285
-104
-0.1% -$1.79K ﹤0.01% 3528
2024
Q4 		$2.27M Hold
115,389
– – ﹤0.01% 3526
2024
Q3 		$2.4M Buy
115,389
+1,683
+1% +$34K ﹤0.01% 3497
2024
Q2 		$2.25M Sell
113,706
-13,975
-11% -$247K ﹤0.01% 3520
2024
Q1 		$2.18M Buy
127,681
+610
+0.5% +$11.1K ﹤0.01% 3567
2023
Q4 		$3M Buy
127,071
+14,322
+13% +$467K ﹤0.01% 3456
2023
Q3 		$5.86M Buy
112,749
+21,485
+24% +$1.29M ﹤0.01% 3177
2023
Q2 		$7.18M Buy
91,264
+8,048
+10% +$577K ﹤0.01% 3131
2023
Q1 		$3.45M Buy
83,216
+1,590
+2% +$73.1K ﹤0.01% 3476
2022
Q4 		$2.61M Buy
81,626
+42
+0.1% +$1.34K ﹤0.01% 3569
2022
Q3 		$3.48M Buy
81,584
+25,409
+45% +$1.47M ﹤0.01% 3509
2022
Q2 		$2.99M Sell
56,175
-9,658
-15% -$533K ﹤0.01% 3630
2022
Q1 		$4.82M Buy
65,833
+633
+1% +$67.3K ﹤0.01% 3548
2021
Q4 		$9.81M Buy
65,200
+13,476
+26% +$2.19M ﹤0.01% 3215
2021
Q3 		$7.83M Buy
51,724
+24,340
+89% +$3.54M ﹤0.01% 3387
2021
Q2 		$4.61M Buy
27,384
+22,384
+448% +$4.94M ﹤0.01% 3647
2021
Q1 		$1.7M Buy
+5,000
New +$1.71M ﹤0.01% 3902

Other funds holding IMA

BOCH
Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $59.6M AUM 181.61% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group's IMA Position: Q4 2025 in Review

Vanguard Group increased its ImageneBio Inc (IMA) stake by 2% in Q4 2025, buying an estimated $34.4K and bringing the position to 238,000 shares worth $1.64M. The position accounts for ﹤0.01% of the portfolio, ranked #3622.

Vanguard Group first reported a position in IMA in Q1 2021 and has held it in 20 quarters since. The position peaked at $9.81M in Q4 2021. 41 funds tracked by Wall St. Rank hold IMA as of Q4 2025.

  • Vanguard Group held 238,000 shares of ImageneBio Inc worth $1.64M as of Q4 2025.
  • Vanguard Group bought 4,642 ImageneBio Inc shares in Q4 2025, an estimated $34.4K.
  • ImageneBio Inc made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3622 holding.
  • Vanguard Group first reported a position in ImageneBio Inc in Q1 2021 and has held it in 20 quarters since.
  • Vanguard Group's ImageneBio Inc position peaked at $9.81M in Q4 2021.
  • 41 funds tracked by Wall St. Rank held ImageneBio Inc as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.